Cronos Group is a leading global cannabinoid company focused on the research, development, and production of smoked and non-smoked cannabis products. The company operates multiple brands and offers a wide range of cannabis-based products, including oils, capsules, and edibles, catering to both medicinal and recreational markets. Cronos Group is committed to innovative research and development efforts aimed at advancing the cannabis industry, and it emphasizes sustainability and compliance with regulatory standards across its operations. By leveraging strategic partnerships and investments in technology, the company seeks to enhance its market presence and drive growth in the evolving landscape of cannabis consumption. Read More
Despite facing potential tariffs on its cannabis imports to Israel, retail sentiment surged, reflecting optimism around the company’s performance and future growth prospects.
Cronos reported first-quarter revenue of $32.26 million, beating analyst estimates of $31.70 million, according to Benzinga Pro. The company reported first-quarter earnings of 2 cents per share, beating estimates for a loss of 1 cent per share.
Getting too high can be a pretty terrible experience. What starts off as a calm, relaxing buzz can quickly spiral into paranoia and anxiety. One minute you’re chilling, the next your mind is racing with worst-case scenarios, and everything feels like it’s falling apart. No one enjoys that kind of high.
Getting too high can be a pretty terrible experience. What starts off as a calm, relaxing buzz can quickly spiral into paranoia and anxiety. One minute you’re chilling, the next your mind is racing with worst-case scenarios, and everything feels like it’s falling apart. No one enjoys that kind of high.
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET.
TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 first quarter earnings conference call on Thursday, May 8, 2025 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.
TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc.’s (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) best-selling cannabis brand, Spinach®, is thrilled to introduce three all-new 1.2g vape products, each expertly crafted with premium THC and enhanced with rare cannabinoids for a uniquely elevated experience. Along with these innovative vape offerings, Cronos is also unveiling new SOURZ by Spinach® Fully Blasted flavors, infused with rare cannabinoids.
This year, an unusual overlap is happening: Easter Sunday and the unofficial cannabis celebration known as 420 both land on April 20. It’s a rare coincidence that hasn’t occurred in more than a decade. While Easter is a sacred day for Christians, marking the resurrection of Jesus, 420 is widely recognized by cannabis users as a day to celebrate marijuana culture.
This year, an unusual overlap is happening: Easter Sunday and the unofficial cannabis celebration known as 420 both land on April 20. It’s a rare coincidence that hasn’t occurred in more than a decade. While Easter is a sacred day for Christians, marking the resurrection of Jesus, 420 is widely recognized by cannabis users as a day to celebrate marijuana culture.
